Park S, Lu GL, Zheng YC, Davison EK, Li Y (2025) Nanoparticle-based delivery strategies for combating drug resistance in cancer therapeutics. Cancers (Basel) 17(16):2628. doi: 10.3390/cancers17162628 PMID: 40867257
Objective: To explore how nanoparticle-based drug delivery systems can address the challenge of resistance to chemotherapy and targeted therapy by improving drug accumulation in tumors, enhancing targeting specificity, and enabling controlled or stimulus-responsive drug release.
Summary: Nanoparticle-based drug delivery strategies offer a promising and multifaceted approach to overcoming multidrug resistance in cancer therapy. Nanocarriers can address many limitations and challenges associated with conventional chemotherapy by enhancing the intracellular drug accumulation at tumor sites, bypassing efflux transporters, facilitating targeted delivery, and enabling in vivo gene modulation.
Usage: Lipid-saporin nanoparticles were utilized to bypass efflux transporters via the co-delivery of anticancer drugs with ABC transporters, leading to an increase in intracellular drug concentrations and the re-sensitization of drug-resistant cancer cells to chemotherapy.
Related Products: Saporin (Cat. #PR-01)